HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabeth Silberhorn Selected Research

Nisoldipine

4/2007Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension.
9/2006Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabeth Silberhorn Research Topics

Disease

2Essential Hypertension
04/2007 - 09/2006
1Adenoviridae Infections (Adenovirus Infections)
10/2023
1Infections
10/2023
1Insulin Resistance
09/2006

Drug/Important Bio-Agent (IBA)

2Antihypertensive Agents (Antihypertensives)IBA
04/2007 - 09/2006
2NisoldipineFDA Link
04/2007 - 09/2006
2Calcium Channel Blockers (Blockers, Calcium Channel)IBA
04/2007 - 09/2006
2Telmisartan (Micardis)FDA Link
04/2007 - 09/2006
1RNA (Ribonucleic Acid)IBA
10/2023
1Nucleosomes (Nucleosome)IBA
10/2023
1ChromatinIBA
10/2023
1NucleoproteinsIBA
10/2023
1Angiotensin Receptor AntagonistsIBA
04/2007
1AdiponectinIBA
09/2006
1Insulin (Novolin)FDA Link
09/2006